[ Price : $8.95]
FDA approves Novartis Radioligand Therapy manufacturing facility in Millburn, NJ to manufacture prostate cancer therapy Pluvicto, ...[ Price : $8.95]
New research on drug direct-to-consumer television advertising finds that viewers misinterpreted certain oncology clinical trial e...[ Price : $8.95]
Federal Register notice: FDA issues a priority review voucher to Pharming Technologies that was related to its rare pediatric dise...[ Price : $8.95]
Federal Register notice: FDA issues a priority review voucher to Pharming Technologies that was related to its rare pediatric dise...[ Price : $8.95]
FDA provides further clarification about a safety alert issued earlier this month that recommended against the use of certain surg...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Acute Radiation Syndrome: Developing Drugs for Prevention a...[ Price : $8.95]
FDA releases the form FDA-483 with 10 observations from a recent inspection at a Lupin drug manufacturing facility in Pithampur, I...[ Price : $8.95]
Sarepta raises several points for FDA consideration on an agency draft product-specific guidance for golodirsen.